rimonabant

(redirected from Accomplia)

rimonabant

A selective cannabinoid-1 receptor blocker that has been shown to reduce body weight and the risk of cardiovascular disease in obese people. The drug has been shown capable of achieving substantial weight loss and reducing cardiovascular risk factors. It has aroused excitement among drug manufacturers who hope it may prove effective in the control of smoking as well as excessive calorie and alcohol intake.
References in periodicals archive ?
health advisers rejected the Accomplia weight-loss drug on safety concerns.
At sanofi-aventis researchers have found that the company's obesity pill Accomplia helps to control blood sugar levels in patients with type 2 diabetes.
The pill ( known as Accomplia or Ribonabant ( could be available as early as next year.
Sanofi-Aventis might have a chance at getting approval for its obesity drug Accomplia (rimonabant) with data it's already compiled.
Ira Loss, an analyst who follows Washington developments that affect the pharmaceutical industry, said if the FDA adopts the panel's recommendations, Sanofi-Aventis might have a chance at getting approval for its obesity drug Accomplia (rimonabant) with data it's already compiled.
federal health advisers' rejection of the company's Accomplia weight-loss drug.
Evaluate the relative safety, efficacy and cost of currently marketed obesity drugs with this report's comparative analysis of Rx and OTC medications including Alli, Meridia, Xenical and Accomplia.
Accomplia, a breakthrough anti-obesity drug, had first-quarter sales of 15 million euros ($20 million), the company said, noting it has been used by more than 130,000 patients since its European launch in June last year.